Ron Akehurst

Cost-utility analysis of deferasirox compared to standard therapy with desferrioxamine for patients requiring iron chelation therapy in the United Kingdom*

J. Karnon, R. Akehurst, K. Tolley, 2008, Current medical research and opinion.

Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra.

M. Sculpher, J. Brazier, A. Briggs, 2005, Health economics.

The cost-effectiveness of celecoxib vs diclofenac in the treatment of osteoarthritis in the UK; an update to the NICE model using data from the CONDOR trial

N. Brereton, B. Winn, Ron Akehurst, 2012, Journal of medical economics.

The implications of contact with the mentor for preregistration nursing and midwifery students.

R. Akehurst, M. Lloyd Jones, S. Walters, 2001, Journal of advanced nursing.

Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis

P. Tappenden, B. Sharrack, J. Madan, 2010, Bone Marrow Transplantation.